Arkolith/Funds/Valence8 US LP

Valence8 US LP

CIK 1943819
Holdings as of Jun 30, 2026·disclosed Aug 6, 2026·~37-day 13F lag·13F-HR
Active Filer

Valence8 US LP holds a concentrated book of 15 reported positions worth $300.5M as of Q2 2026 (disclosed Aug 6, 2026, a ~37-day 13F lag). This quarter they opened SS Health Care Select Sector and trimmed SS SPDR BB 1-3M T-Bill ETF. Their largest long position is Ishares Msci USA Quality Fac at 30% of the reported non-option book. Cloning the disclosed picks since 2025 would be +27% (+24.6%/yr). That is a simulation of the disclosed long book, not audited returns.

Opened
1
bought for the first time
Sold out
0
exited the position entirely
nothing exited

Growth of $10,000: cloning the disclosed book

If you'd copied them
+27.4%
+24.6%/yr · since Aug '25
Their reported book
+25.7%
held from quarter-end
S&P 500
+21.9%
same window
$10K$11K$11K$12K$13KAug '25Oct '25Jan '26Apr '26Jun '26Sep '26
Valence8 US LP (copied at disclosure) S&P 500

Following at the filing date actually beat the quarter-end book by 1.8 points over this window.

Growth of $10,000 cloning Valence8 US LP's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~37 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.

How much sits in the biggest positions

Top-heavy: concentrated book

Top 5 holdings
72%
Top 10 holdings
93%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Where the money is, by sector

0% mapped to company sectors

ETFs / funds
94%
No sector on file yet
6%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis

Bought
Trimmed / exited

Funds with the most overlap

Other tracked managers holding the same core names as Valence8 US LP

Manager / fundShared namesTheir $ in those
Client First Capital LLC3 / 15$89.8M
Wallace Hart LLC2 / 15$56.0M
Permanens Capital L.P.3 / 15$322.6M
Ebert Capital Management Inc.3 / 15$34.2M
Diesslin Group, Inc.2 / 15$81.8M
Aragon Global Management, LP3 / 15$79.7M
Bitterroot Capital Advisors LLC3 / 15$49.4M
Kennicott Capital Management LLC4 / 15$64.2M

Ranked by the share of each fund's own book sitting in the names it shares with Valence8 US LP: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.

Holdings: largest first

Bars show each position's share of the portfolio. Click a row for its position history.

15 positions
#SecurityValueShares% PortLast moveHistory
1Ishares TR
MSCI USA QLT FCT
$90.4M412.1K
30.1%
+22%
Added · +75K sh
2Invesco QQQ TR
UNIT SER 1
$51.5M69.9K
17.1%
+20%
Added · +11K sh
3SPDR Series Trust
ST STR BLO 1 ETF
$28.2M307.3K
9.4%
−53%
Reduced · −351K sh
4Ishares TR
MSCI INTL QUALTY
$26.1M527.4K
8.7%
−38%
Reduced · −319K sh
5Select Sector SPDR TR
ST STR STAPL ETF
$19.2M231.6K
6.4%
+79%
Added · +102K sh
6Select Sector SPDR TR
ST STR CARE ETF
$14.8M93.4K
4.9%
New
New position
7Vanguard Index FDS
VALUE ETF
$14.7M67.4K
4.9%
+132%
Added · +38K sh
8Vaneck ETF Trust
SEMICONDUCTR ETF
$13.7M20.9K
4.6%
−61%
Reduced · −32K sh
9Ishares TR
EAFE VALUE ETF
$12.7M166.3K
4.2%
−40%
Reduced · −112K sh
10TCW ETF Trust
TRANS SYSTE ETF
$6.7M54.7K
2.2%
−36%
Reduced · −31K sh
11Select Sector SPDR TR
ST STR UTIL ETF
$6.3M138.2K
2.1%
+119%
Added · +75K sh
12Ishares TR
MSCI UK ETF NEW
$5.6M121.3K
1.9%
+1.0%
Added · +1K sh
13Vaneck ETF Trust
GOLD MINERS ETF
$4.6M61.2K
1.5%
Held
14Ishares Inc
MSCI STH KOR ETF
$3.0M15.1K
1.0%
−68%
Reduced · −31K sh
15Global X FDS
GLOBAL X COPPER
$2.8M37.0K
0.9%
Held
Showing all 15 positions
Build

Ask your agent what Valence8 US LP owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1943819/holdings"
Ask your agent
Use Arkolith to show Valence8 US LP's latest
holdings, largest changes, and filing provenance.

Filing history

As-of date vs the date the SEC received each filing

$337.5M · Q4 2025Q2 2025 · $237.6MQ2 2026 · $300.5M

Reported 13F total per quarter. Raw filing totals can include option notional.

QuarterAs ofFiledLagPositionsValueForm
Q2 2026Jun 30, 2026Aug 6, 202637d15$300.5M13F-HR
Q1 2026Mar 31, 2026May 15, 202645d14$286.1M13F-HR
Q4 2025Dec 31, 2025Feb 9, 202640d15$337.5M13F-HR
Q3 2025Sep 30, 2025Nov 7, 202538d14$291.7M13F-HR
Q2 2025Jun 30, 2025Aug 7, 202538d12$237.6M13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.